What is Androderm
TestosteroneThe Generic name of this drug
Treatment SummaryTestosterone is a hormone used to treat male sexual development issues. It works by binding to androgen receptors in the body, activating genes that cause the growth of male sex organs and other masculine traits. Testosterone was first discovered in 1935 through samples and synthetic creation.
Androdermis the brand name
Androderm Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Androderm
Testosterone
1995
90
Approved as Treatment by the FDA
Testosterone, commonly known as Androderm, is approved by the FDA for 12 uses including Gonadotrophin releasing hormone deficiency and Hypogonadism .Gonadotrophin releasing hormone deficiency
Helps manage Gonadotrophin releasing hormone deficiency
Hypogonadism
Helps manage Idiopathic Hypogonadotropic Hypogonadism
Orchitis
Helps manage Orchitis
Hypergonadotropic Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Hypothalamo-pituitary disorder
Helps manage Hypothalamo-pituitary disorder
Hypogonadotropic hypogonadism
Breast
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Orchidectomy
Helps manage Orchidectomy
1 to 5 years post-menopausal
Used to treat 1 to 5 years post-menopausal in combination with Testosterone enanthate
Puberty, Delayed
Used to treat Puberty, Delayed in combination with Testosterone enanthate
vanishing testis syndrome
Helps manage vanishing testis syndrome
Torsion of testis
Helps manage Torsion of testis
Effectiveness
How Androderm Affects PatientsTestosterone is a hormone that helps develop male sex organs and secondary sexual characteristics. Its effects vary from person to person, but generally last between 10-100 minutes. A typical adult man will have a testosterone level of 300-1000ng/dL, which is considered safe. It is important to note that children who come into contact with testosterone products may also experience its effects, so caution should be used when applying.
How Androderm works in the bodyThe androgen receptor helps the body develop masculine characteristics. It binds to testosterone and other hormones, which are carried into the nucleus of cells. Here, these hormones interact with DNA and other regulators to activate certain genes. This process is responsible for sexual development, including the growth of the prostate, penis, and scrotum. Testosterone also causes secondary sexual characteristics like facial and body hair, a deeper voice, and changes in muscle and fat distribution.
When to interrupt dosage
The measure of Androderm is dependent upon the indicated illness, such as Gonadotrophin releasing hormone deficiency, Orchidectomy and Orchitis. The dosage amount depends on the administration approach delineated in the table beneath.Condition
Dosage
Administration
Orchidectomy
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Breast
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
1 to 5 years post-menopausal
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypogonadism
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
vanishing testis syndrome
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Orchitis
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypergonadotropic Hypogonadism
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Gonadotrophin releasing hormone deficiency
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypogonadotropic hypogonadism
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Puberty, Delayed
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Torsion of testis
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypothalamo-pituitary disorder
, 75.0 mg, 0.01 mg/mg, 37.5 mg, 50.0 mg, 100.0 mg, 200.0 mg, 1.0 %, 4.5 %, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 0.05 mg/mg, 24.3 mg, 12.2 mg, 0.0405 mg/mg, 0.025 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 12.5 mg/pump actuation, 100.0 mg/mL, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Warnings
Androderm has two contraindications. It should not be employed for the conditions enumerated in the table below.Androderm ContraindicationsCondition
Risk Level
Notes
Breast Cancer
Do Not Combine
suspected pregnancy
Do Not Combine
Common Androderm Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Testosterone.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Testosterone.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Testosterone.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Testosterone.
Astemizole
Major
The metabolism of Astemizole can be increased when combined with Testosterone.
Androderm Toxicity & Overdose RiskThere is limited information about overdosing on topical testosterone products. If an injectable product is overdosed, a stroke may occur. To treat an overdose, stop taking the testosterone product, clean the skin with soap and water if the product was topical, and provide supporting treatments.
Androderm Novel Uses: Which Conditions Have a Clinical Trial Featuring Androderm?
10 active investigations are assessing the potential of Androderm for alleviating Orchitis, Testicular Torsion and Hypothalamo-pituitary Dysfunction.Condition
Clinical Trials
Trial Phases
Breast
0 Actively Recruiting
Gonadotrophin releasing hormone deficiency
2 Actively Recruiting
Phase 1
Hypogonadotropic hypogonadism
0 Actively Recruiting
Torsion of testis
0 Actively Recruiting
vanishing testis syndrome
0 Actively Recruiting
Orchitis
0 Actively Recruiting
Hypogonadism
8 Actively Recruiting
Phase 1, Phase 4, Phase 2
Orchidectomy
0 Actively Recruiting
Puberty, Delayed
1 Actively Recruiting
Phase 1
Hypothalamo-pituitary disorder
0 Actively Recruiting
1 to 5 years post-menopausal
0 Actively Recruiting
Hypergonadotropic Hypogonadism
0 Actively Recruiting
Androderm Reviews: What are patients saying about Androderm?
5Patient Review
9/27/2012 I've only been taking this for a week, and I'm already seeing better performance in the gym. My recovery time is shorter, and my libido has increased. I would gladly pay out of pocket to keep taking this medication because it's improved my quality of life so much.
3.7Patient Review
5/16/2014 This treatment really helped me out. My drive increased and it almost always cured my ED. I had more energy, which was great for getting things done around the house. The only downside is that it can make you a bit more aggressive; but overall, I'm really happy with this product!
3Patient Review
7/6/2016 The 4mg patch has really helped me with my energy levels and muscle shaping.
2.7Patient Review
3/11/2017 I'll update this review after I've used the product for a longer period of time. For now, I want to leave a note about the company. I reached out with some questions but they were unhelpful because all they do is sell the product. This seems like very basic information that should be readily available to customers.
2.7Patient Review
4/23/2012 My husband started using the 4mg Androderm patches and noticed enlarged NON-tender lymph nodes in his neck. Has anyone had this experience?? He has a history of Hodgkin's lymphoma so he's seen his oncologist & has a biopsy scheduled. I'd rather this be some sort of rare reaction to the patches verses a Hodgkin's relapse.
2.7Patient Review
1/29/2021 I'm 73 and think I might have age-related hormone deficiencies. In the past, I've used testosterone shots, gel, and now patches. The shots were uncomfortable, the gel was messy, and the patches are leaving itchy red welts that last weeks--on top of being very expensive. Not happy with any of these options.
2.3Patient Review
9/4/2012 I was on this medication for six weeks. It gave me more energy at first, but then stopped working and started causing deep burning pain in my arms and shoulders. Has anyone else experienced this side effect?
2.3Patient Review
1/23/2015 The Androderm patch unfortunately gave me prostatitis, insomnia, and a general feeling of malaise.
2Patient Review
9/24/2014 My Total T level at start was 234 My free was also very low. After 6 weeks on 4mg Androderm patch my levels were again checked. Total Testosterone NINETY SIX !!!! Free almost non existent!! WTF?? Doctor started me injections immediately. This stuff made me worse? How can it DROP you that far?
1.7Patient Review
12/8/2012 This medication didn't provide any benefits for me. A waste of time and money.
1.3Patient Review
3/31/2013 Unfortunately, my testosterone levels dropped even lower after using the androderm patch for just one month.
1Patient Review
8/26/2020 I took Androderm for 31 days and had no change in my testosterone levels. Consequently, I would not recommend this treatment to anyone.
Patient Q&A Section about androderm
How long does it take Androderm to work?
"It takes three weeks for the effects of this medication to start showing on sexual interest, and these effects will stay the same for six weeks with no chance of increasing. Changes in erections and ejaculations could take up to six months to show. The effects of this medication on quality of life should start to show within three to four weeks, but the maximum benefits will take longer." - Anonymous Online Contributor
Unverified Answer
Is Androderm safe?
"Androderm can also cause less serious side effects, such as skin reactions where the patch is applied.
The testosterone patch Androderm can cause life-threatening blood clots in your legs or lungs. Symptoms of a clot in the legs include leg pain, swelling, or redness. Symptoms of a clot in the lungs include difficulty breathing or chest pain. Androderm can also cause less serious side effects, such as skin reactions where the patch is applied." - Anonymous Online Contributor
Unverified Answer
What is Androderm used for?
"This medication is used to supplement the testosterone levels in men who are not able to produce enough on their own. The medication is absorbed through the skin and enters the bloodstream, where it helps the body to reach normal testosterone levels." - Anonymous Online Contributor
Unverified Answer
Do you need a prescription for Androderm?
"ANDRODERM is a prescription medicine that contains testosterone and is used to treat adult males who have low or no testosterone due to certain medical conditions. Your healthcare provider will test your blood for testosterone before you start and while you are taking ANDRODERM." - Anonymous Online Contributor
Unverified Answer